Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,861,283
  • Shares Outstanding, K 296,199
  • Annual Sales, $ 399,360 K
  • Annual Income, $ -151,580 K
  • 60-Month Beta 0.80
  • Price/Sales 6.92
  • Price/Cash Flow N/A
  • Price/Book 20.92
Trade FOLD with:

Options Overview Details

View History
  • Implied Volatility 36.33% ( +4.36%)
  • Historical Volatility 39.66%
  • IV Percentile 3%
  • IV Rank 23.25%
  • IV High 91.49% on 08/08/23
  • IV Low 19.62% on 05/07/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 86
  • Volume Avg (30-Day) 468
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 12,152
  • Open Int (30-Day) 12,329

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.06
  • Number of Estimates 5
  • High Estimate -0.04
  • Low Estimate -0.09
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.02 +7.10%
on 05/13/24
10.93 -11.62%
on 04/23/24
-1.00 (-9.38%)
since 04/15/24
3-Month
9.02 +7.10%
on 05/13/24
14.02 -31.10%
on 02/27/24
-4.34 (-31.00%)
since 02/15/24
52-Week
9.02 +7.10%
on 05/13/24
14.57 -33.70%
on 12/28/23
-1.54 (-13.75%)
since 05/15/23

Most Recent Stories

More News
Stock Index Futures Tread Water Ahead of Key U.S. PPI Data and Powell Remarks

June S&P 500 E-Mini futures (ESM24) are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.03% this morning as investors geared up for crucial U.S. producer inflation data while also awaiting...

ESM24 : 5,334.50 (+0.03%)
NQM24 : 18,717.75 (+0.14%)
INCY : 57.05 (unch)
INTC : 31.27 (+0.71%)
SQSP : 43.15 (-0.09%)
AMAT : 217.49 (+3.66%)
HD : 348.67 (+2.40%)
ALC.Z.IX : 81.280 (+0.40%)
DHER.D.DX : 32.040 (+2.74%)
RHM.D.DX : 516.400 (+0.10%)
FULC : 8.25 (+4.30%)
FOLD : 9.66 (+3.54%)
Amicus Therapeutics: Q1 Earnings Snapshot

Amicus Therapeutics: Q1 Earnings Snapshot

FOLD : 9.66 (+3.54%)
2 ‘Strong-Buy’-Rated Stocks With Around 50% Upside

Wall Street predicts that these rapidly expanding growth stocks will generate outsized gains this year.

$SPX : 5,308.15 (+1.17%)
$NASX : 16,742.39 (+1.40%)
CVE : 20.17 (-0.10%)
FOLD : 9.66 (+3.54%)
NGG24 : 2.490s (-8.19%)
Amicus Therapeutics: Q3 Earnings Snapshot

Amicus Therapeutics: Q3 Earnings Snapshot

FOLD : 9.66 (+3.54%)
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates...

FOLD : 9.66 (+3.54%)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023

Stocks that traded heavily or had substantial price changes on Friday: Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall

OPK : 1.3500 (+3.45%)
MTN : 201.00 (-2.25%)
FOLD : 9.66 (+3.54%)
BLK : 815.70 (+1.59%)
NKE : 91.67 (-1.21%)
WuXi Biologics Reports Solid 2023 Interim Results

Revenue Increased by 17.8% Y-o-Y to RMB8,492.0 Million Adjusted Net Profit Rose by 0.4% to RMB2,925.6 Million Non-COVID Revenue Achieved 59.7% Y-o-Y Growth,...

FOLD : 9.66 (+3.54%)
Amicus Therapeutics: Q2 Earnings Snapshot

Amicus Therapeutics: Q2 Earnings Snapshot

FOLD : 9.66 (+3.54%)
Company News for May 11, 2023

Companies in The news Are: VSH,COHRICL,FOLD

FOLD : 9.66 (+3.54%)
VSH : 23.72 (+1.67%)
COHR : 57.08 (+0.76%)
ICL : 4.79 (+0.21%)
Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Grow

Amicus (FOLD) incurs wider-than-expected loss in the first quarter. Revenues, however, beat estimates. The company reiterates its 2023 guidance.

FOLD : 9.66 (+3.54%)
RCUS : 17.55 (+2.57%)
ALLO : 2.98 (+0.68%)
OCUP : 1.7300 (+1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Amicus Therapeutics, Inc. is a global patient-centric biotechnology company engaged in the discovery, development and commercialization of a diverse set of novel treatments for patients living with rare metabolic diseases.'The company has one marketed medicine in its portfolio named Galafold which is...

See More

Key Turning Points

3rd Resistance Point 10.14
2nd Resistance Point 9.97
1st Resistance Point 9.81
Last Price 9.66
1st Support Level 9.48
2nd Support Level 9.31
3rd Support Level 9.15

See More

52-Week High 14.57
Fibonacci 61.8% 12.45
Fibonacci 50% 11.80
Fibonacci 38.2% 11.14
Last Price 9.66
52-Week Low 9.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar